Syngene International Limited (NSE:SYNGENE)
India · Delayed Price · Currency is INR 434.85
-0.20 (-0.05%)
Feb 17, 2026, 10:40 AM IST
Syngene International Market Cap
Syngene International has a market cap or net worth of 173.19 billion as of February 13, 2026. Its market cap has decreased by -41.47% in one year.
Market Cap
173.19B
Enterprise Value
168.10B
Revenue
37.20B
Ranking
n/a
PE Ratio
54.65
Stock Price
434.85
Market Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 173.19B, an increase of 178.85%. That is a compound annual growth rate of 10.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 16, 2026 | 173.19B | -33.17% |
| Dec 31, 2025 | 259.16B | -24.09% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.07T |
| Divi's Laboratories | 1.64T |
| Apollo Hospitals Enterprise | 1.08T |
| Cipla | 1.08T |
| Piramal Pharma | 220.36B |
| Eris Lifesciences | 195.93B |
| Sai Life Sciences | 193.61B |
| Alembic Pharmaceuticals | 151.33B |